Analysis of the immunogenicity and stability of a porcine pulmonary surfactant preparation administered in rabbits

Precioso, Alexander R; Sakae, Paula P. O; Mascaretti, Renata S; Kubrusly, Flávia S; Gebara, Vera C. B. Cainelli; Iourtov, Dmitri; Rebello, Celso M; Vaz, Flávio A. C; Raw, Isaías.
Clinics ; 61(2): 153-160, Apr. 2006. graf
Artículo en Inglés | LILACS, SES-SP | ID: lil-426297

Documentos relacionados

  1. Analysis of the immunogenicity and stability of a porcine pulmonary surfactant preparation administered in rabbits.
  2. Pulmonary surfactant: an immunological perspective.
  3. On the molecular determinants of the SARS-CoV-2 attack.
  4. Diverse functions of pulmonary collectins in host defense of the lung.
  5. Failure to detect surfactant protein-specific antibodies in sera of premature infants treated with survanta, a modified bovine surfactant.
  6. Efficacy of synthetic surfactant (CHF5633) bolus and/or lavage in meconium-induced lung injury in ventilated newborn rabbits.
  7. Dissociation of surfactant protein B from canine surfactant large aggregates during formation of small surfactant aggregates by in vitro surface area cycling.
  8. Pulmonary surfactant and tuberculosis.
  9. [Possibility of directed changes in the surface activity of rat pulmonary surfactants by means of exposure to antibodies specific to them].
  10. Comment on "Bilayer aggregate microstructure determines viscoelasticity of lung surfactant suspensions" by C. O. Ciutara and J. A. Zasadzinski, <i>Soft Matter</i>, 2021, <b>17</b>, 5170-5182.